RedHill Biopharma (RDHL) Gains from Investment Securities (2015)
RedHill Biopharma's (RDHL) quarterly Gains from Investment Securities came in at $1.0 million in Q3 2015.
Powered by 
Analysis
RedHill Biopharma (RDHL) Gains from Investment Securities (2015) Analysis & Trends
RedHill Biopharma (RDHL) has reported Gains from Investment Securities for 1 consecutive years, with $1.0 million the latest figure, recorded in Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 10.63 Mn | 10.63 Mn | - |